Alexion Pharmaceuticals Inc ALXN:NASDAQ

Last Price$102.78NASDAQ Closing Price as of 4:00PM ET 8/12/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change+1.54(1.52%)
Bid (Size)$102.21 (1)
Ask (Size)$102.77 (6)
Day Low / High$100.78 - 103.00
Volume1.6 M
  • Latest Stories
  • Commentary and Analysis
2020 and 2021 Estimates for Alexion Pharmaceuticals Targeted Higher but Q3 Earnings Number Reduced
11:50PM ET 7/31/2020 MT Newswires

Alexion Pharmaceuticals Inc's (NASDAQ:ALXN, Recent Price: 102.49) forecasted earnings estimates for Q3 ending September 30, 2020, and the full year...

--Analyst Actions: William Blair Downgrades Alexion Pharmaceuticals to Market Perform From Outperform
12:56PM ET 7/31/2020 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Analyst Actions: Raymond James Cuts Alexion Pharmaceuticals' Price Target to $151 From $156, Keeps at Outperform
11:03AM ET 7/31/2020 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Analyst Actions: Wedbush Lifts Price Target on Alexion Pharmaceuticals to $156 From $142, Maintains Outperform
9:16AM ET 7/31/2020 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Analyst Actions: JP Morgan Hikes Alexion Pharmaceuticals' Price Target to $167 From $158, Maintains Overweight Rating
9:11AM ET 7/31/2020 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Analyst Actions: Goldman Sachs Raises Price Target for Alexion Pharmaceuticals to $121 From $117, Maintains Neutral Rating
9:11AM ET 7/31/2020 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Analyst Actions: SVB Leerink Lifts Alexion Pharmaceuticals' Price Target to $163 From $159, Keeps at Outperform
9:09AM ET 7/31/2020 MT Newswires

Alexion Pharmaceuticals (ALXN)has an average buy rating among analysts, with an average price target of $145. (MT Newswires covers equity, commodity and...

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Alexion Pharmaceuticals, Inc.
3:55PM ET 7/30/2020 MT Newswires

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...

--Analyst Actions: Wedbush Lifts Price Target for Alexion Pharmaceuticals to $156 From $142, Maintains Outperform Rating
3:39PM ET 7/30/2020 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Alexion Pharmaceuticals Posts Higher Q2 EPS, Revenue; Updates 2020 Outlook
9:36AM ET 7/30/2020 MT Newswires

Alexion Pharmaceuticals (ALXN) said Thursday it had Q2 non-GAAP earnings of $3.11 per diluted share, up from $2.64 a year earlier. Analysts polled by...